| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |